Discounts, Guarantees and the Search for ‘Good’ Genes: The Booming Fertility Business

Alyssa, 3, walks by her mother, Julie Schlomer, as she comforts her twin brother, Logan, after he became upset about going down a slide at the Maryland Zoo in Baltimore during a special families event hosted by Shady Grove Fertility, the Rockville clinic that helped Schlomer have the children via a shared egg donor and in vitro fertilization. (Carolyn Van Houten/The Washington Post)
Alyssa, 3, walks by her mother, Julie Schlomer, as she comforts her twin brother, Logan, after he became upset about going down a slide at the Maryland Zoo in Baltimore during a special families event hosted by Shady Grove Fertility, the Rockville clinic that helped Schlomer have the children via a shared egg donor and in vitro fertilization. (Carolyn Van Houten/The Washington Post)
TT

Discounts, Guarantees and the Search for ‘Good’ Genes: The Booming Fertility Business

Alyssa, 3, walks by her mother, Julie Schlomer, as she comforts her twin brother, Logan, after he became upset about going down a slide at the Maryland Zoo in Baltimore during a special families event hosted by Shady Grove Fertility, the Rockville clinic that helped Schlomer have the children via a shared egg donor and in vitro fertilization. (Carolyn Van Houten/The Washington Post)
Alyssa, 3, walks by her mother, Julie Schlomer, as she comforts her twin brother, Logan, after he became upset about going down a slide at the Maryland Zoo in Baltimore during a special families event hosted by Shady Grove Fertility, the Rockville clinic that helped Schlomer have the children via a shared egg donor and in vitro fertilization. (Carolyn Van Houten/The Washington Post)

When Julie Schlomer got the news that she was finally pregnant at the age of 43, her thoughts turned to the other mothers. There were three of them in all, complete strangers, but they shared an extraordinary bond made possible by 21st-century medicine and marketing.

They were all carrying half-siblings.

Under a cost-saving program offered by Rockville-based Shady Grove Fertility, the women split 21 eggs harvested from a single donor — blue-eyed, dark-haired, with a master’s degree in teaching. Each had the eggs fertilized with her partner’s sperm and transferred to her womb.

Schlomer gave birth to twins, a son and daughter, now 3. She hopes her children will one day connect with their genetic half-siblings.

“I would love to see pictures of the other kids, to talk to them,” Schlomer said.

The multibillion-dollar fertility industry is booming, and experimenting with business models that are changing the American family in new and unpredictable ways. Would-be parents seeking donor eggs and sperm can pick and choose from long checklists of physical and intellectual characteristics. Clinics now offer volume discounts, package deals and 100 percent guarantees for babymaking that are raising complicated ethical and legal questions.

According to the Centers for Disease Control and Prevention, 12 percent of American women 15 to 55 — 7.3 million — have used some sort of fertility service; the use of assisted reproductive technologies has doubled in the past decade. In 2015, these procedures resulted in nearly 73,000 babies — 1.6 percent of all US births. The rate is even higher in some countries, including Japan (5 percent) and Denmark (10 percent).

Most couples use their own eggs and sperm, turning to doctors to facilitate pregnancy through techniques such as in vitro fertilization (IVF). But the use of donor gametes is on the rise. The donor-egg industry, in particular, has taken off in the past decade with the development of a safe and reliable egg-freezing process. The number of attempted pregnancies with donor eggs has soared from 1,800 in 1992 to almost 21,200 in 2015.

Yet in the United States, the industry remains largely self-regulated. Questions abound about the recruitment of donors; the ethics of screening and selecting embryos for physical characteristics; the ownership of the estimated millions of unused eggs, sperm samples and embryos in long-term storage; and the emerging ability to tinker with embryos via the gene-editing tool CRISPR.

Earlier this year, a group of donor-conceived adults documented numerous ethical lapses in the industry, including donors who lied to prospective parents about their health histories and other qualifications, and clinics that claimed to have limited donations from some individuals — while permitting those individuals to submit hundreds of samples. They called on the Food and Drug Administration to provide more oversight of the “cryobanks” that gather, store and sell the most precious commodities in the industry — sperm and eggs.

The agency said it is reviewing the matter, but cannot predict when it will have a response “due to the existence of other FDA priorities.”

In the meantime, the business of assisted reproduction remains a mostly unregulated frontier. Shady Grove Fertility, the nation’s largest clinic, offers refunds if couples don’t go home with a baby. New Hope Fertility in New York City held a lottery earlier this year that awarded 30 couples a $30,000 round of IVF. And the California IVF Fertility Center is pioneering what some refer to as the “Costco model” of babymaking, creating batches of embryos using donor eggs and sperm that can be shared among several different families.

That model has served to highlight a preference among many would-be parents for tall, thin, highly-educated donors.

“It’s a little unsettling to be marketing characteristics as potentially positive in a future child,” said Rebecca Dresser, a bioethicist at Washington University in St. Louis and a member of the President’s Council on Bioethics under George W. Bush. “But it’s hard to think on what basis to prohibit that.”

And so, Dresser said, “what we have now is prospective parents making judgments about what they think ‘good’ genes are” — decisions that are literally changing the face of the next generation.

Choosing baby’s traits
When little Louise Joy Brown, the world’s first test-tube baby, came screaming into the world at 5 pounds 12 ounces in 1978, her birth was greeted with as much fear as hope. IVF success rates were low, and some doctors expressed concern about possible harm to the baby and mother. The Roman Catholic Church worried that IVF would lead to the creation of “baby factories.”

Nearly 40 years and 6.5 million assisted births later, the procedures are considered mainstream medicine. And the basic building blocks of human life — sperm and egg — can be found for sale online with a simple Google search.

Prospective parents can filter and sort potential donors by race and ethnic background, hair and eye color, and education level. They also can get much more personal information: audio of the donor’s voice, photos of the donor as a child and as an adult, and written responses to questions that read like college-application essays.

Want your sperm donor to have a B.A. in political science? Want your egg donor to love animals? Want the genes of a Division I athlete? All of these are possible. Prospective parents overwhelmed by all the choices can leave it to the heavens and pick a donor by astrological sign.

A prescreened vial of sperm sells for as little as $400 and can be shipped via FedEx. A set of donor eggs — as many as 30, depending on the donor — can cost $10,000 or more to compensate for the risky and invasive medical procedure required to harvest eggs from the donor’s ovaries.

Fertility companies freely admit that specimens from attractive donors go fast, but it’s intelligence that drives the pricing: Many companies charge more for donors with a graduate degree.

Talent sells, too. One cryobank, Family Creations, which has offices in Los Angeles, Atlanta, Austin and other large cities, notes that a 23-year-old egg donor “excels in calligraphy, singing, modeling, metal art sculpting, painting, drawing, shading and clay sculpting.” A 29-year-old donor “excels in softball, tennis, writing and dancing.”

The Seattle Sperm Bank categorizes its donors into three popular categories: “top athletes,” “physicians, dentists and medical residents,” and “musicians.”

And the Fairfax Cryobank in Northern Virginia, one of the nation’s largest, typically stocks sperm from about 500 carefully vetted donors whose profiles read like overeager suitors on a dating site: Donor No. 4499 “enjoys swimming, fencing and reading and writing poetry.” Donor No. 4963 “is an easygoing man with a quick wit.” Donor No. 4345 has “well-developed pectorals and arm muscles.”

Some companies offer a face-matching service that finds donors who look most like the prospective mom or dad. Or, if they prefer, like Jennifer Lawrence. Or Taye Diggs. Or any other famous person they want their offspring to resemble.

A money-back guarantee
Before they decided to use donor eggs, Schlomer and her husband, Ryan, had been trying to have a baby for two agonizing years. Their insurance paid for those early infertility treatments, but nothing worked. Not intrauterine insemination (which involves having a doctor place sperm inside the uterus during ovulation), not hormone injections, not acupuncture, not herbs.

The couple, from Lexington Park, Md., about 60 miles east of the District on the Chesapeake Bay, was psychologically ready to take the next step. But a set of eggs and up to six attempts at embryo transfers cost $55,000 — none of it covered by insurance.

“I thought it was crazy high. There is no way I could pay for that,” Schlomer recalled. While they both had steady incomes — she as a government contractor in information technology and he as an aerospace engineer for the Navy — they were far from wealthy.

But as they studied the material from Shady Grove Fertility, they discovered that the clinic offered a huge range of payment options, neatly outlined in a nine-by-six grid, 54 possibilities in all. If Schlomer split the eggs with one other mother, the cost would go down to $39,000. If she split the eggs with two other mothers, the cost would be $30,500.

Schlomer’s husband noticed that they could cut the cost even more, to $24,500, if they agreed to use only one set of eggs and forgo the right to ask for more.

Schlomer initially was put off by the idea of sharing; she feared that her offspring could unknowingly meet a half-sibling and fall in love. But more research reassured her that such a meeting was mathematically unlikely, even for half-siblings living in the same geographic area.

What sealed the deal was the money-back guarantee. If Schlomer didn’t get pregnant or they opted to stop, they would get a refund.

This guarantee is the hallmark of Shady Grove. Clinic co-founder Michael Levy, who now serves as the company’s president, drew criticism when he pioneered the model decades ago. “People were calling it ‘contingency medicine’ and saying it is unethical,” he recalled.

Today, he said, about three-fourths of programs nationally offer some kind of guarantee, adding, “I think it’s probably been our most important contribution to the field.”

The Schlomers drained their savings account, borrowed $10,000 from their 401(k) retirement fund and sold a Toyota Prius. Then they set aside a quiet weekend to look for a donor.
Schlomer had two main criteria: One, the donor had to have blue eyes. While her eyes are green, she was charmed by the idea of a child with blue eyes.

Second, the donor had to have a graduate degree. While neither she nor her husband studied beyond the undergraduate level, she explained, “Who doesn’t want smart children?”

She found 12 matches and looked at their profiles. A few of them, she noticed, used horrible grammar in their written responses to some standard profile questions. Those were the first to go. She also crossed off donors with hereditary health issues.

That left two. In the end, they went with the one whose personality spoke most to Julie.

The donor said she was a “homebody” who loves taking pictures and being with family on the beach. Her personal goals, she wrote, include being “the best possible mom I can be for my children. I want to be ‘present’ when I am with them and invest into their lives. . . . I want my life to matter.”

Schlomer put in the order, and it wasn’t long before the clinic found two more women to join her group. Within a few weeks, the eggs were harvested from the donor, fertilized and implanted.

Alyssa and Logan were born in 2013. Both have very blue eyes — “beautiful, big, giant blue eyes,” Schlomer said — and have been very healthy. “They don’t even get colds,” she said. She is grateful that there’s no chance they inherited lupus, a serious autoimmune disorder in which the body attacks its own organs and tissue, that she inherited from her mom.

In the years since, Schlomer has thought about how to tell them the story of their birth.

“I believe babies choose their mothers,” she said. “So I have the same children that I would have had if they had come from my own eggs. They just have a few different physical characteristics.”

“I’m thrilled with the results, as it turns out,” she added.

The Schlomers purchased two books for the twins: “Before You Were Born: Our Wish for a Baby” and “A Tiny Itsy Bitsy Gift of Life, An Egg Donor Story,” which their father occasionally reads at bedtime.

When the time is right, Schlomer thinks she will explain that they are “high-tech babies” and impress on them the importance of memorizing their donor number, in case they happen to “run into another donor-egg kid.”

“I know it’s a really slim chance,” she said. “But I want them to be aware, just in case.”

(The Washington Post)



AI to Track Icebergs Adrift at Sea in Boon for Science

© Jonathan NACKSTRAND / AFP
© Jonathan NACKSTRAND / AFP
TT

AI to Track Icebergs Adrift at Sea in Boon for Science

© Jonathan NACKSTRAND / AFP
© Jonathan NACKSTRAND / AFP

British scientists said Thursday that a world-first AI tool to catalogue and track icebergs as they break apart into smaller chunks could fill a "major blind spot" in predicting climate change.

Icebergs release enormous volumes of freshwater when they melt on the open water, affecting global climate patterns and altering ocean currents and ecosystems, reported AFP.

But scientists have long struggled to keep track of these floating behemoths once they break into thousands of smaller chunks, their fate and impact on the climate largely lost to the seas.

To fill in the gap, the British Antarctic Survey has developed an AI system that automatically identifies and names individual icebergs at birth and tracks their sometimes decades-long journey to a watery grave.

Using satellite images, the tool captures the distinct shape of icebergs as they break off -- or calve -- from glaciers and ice sheets on land.

As they disintegrate over time, the machine performs a giant puzzle problem, linking the smaller "child" fragments back to the "parent" and creating detailed family trees never before possible at this scale.

It represents a huge improvement on existing methods, where scientists pore over satellite images to visually identify and track only the largest icebergs one by one.

The AI system, which was tested using satellite observations over Greenland, provides "vital new information" for scientists and improves predictions about the future climate, said the British Antarctic Survey.

Knowing where these giant slabs of freshwater were melting into the ocean was especially crucial with ice loss expected to increase in a warming world, it added.

"What's exciting is that this finally gives us the observations we've been missing," Ben Evans, a machine learning expert at the British Antarctic Survey, said in a statement.

"We've gone from tracking a few famous icebergs to building full family trees. For the first time, we can see where each fragment came from, where it goes and why that matters for the climate."

This use of AI could also be adapted to aid safe passage for navigators through treacherous polar regions littered by icebergs.

Iceberg calving is a natural process. But scientists say the rate at which they were being lost from Antarctica is increasing, probably because of human-induced climate change.

 


AMD Predicts Weaker First-Quarter Sales, Shares Plunge on Nvidia Comparisons

An AMD logo and a computer motherboard appear in this illustration created on August 25, 2025. (Reuters)
An AMD logo and a computer motherboard appear in this illustration created on August 25, 2025. (Reuters)
TT

AMD Predicts Weaker First-Quarter Sales, Shares Plunge on Nvidia Comparisons

An AMD logo and a computer motherboard appear in this illustration created on August 25, 2025. (Reuters)
An AMD logo and a computer motherboard appear in this illustration created on August 25, 2025. (Reuters)

Advanced Micro Devices on Tuesday forecast a slight decline in quarterly revenue, raising concerns about whether it ​can effectively challenge Nvidia in the booming AI market and sending its shares tumbling 8% in after-hours trade.

The lackluster prediction comes despite an unexpected boost from sales of certain artificial intelligence chips to China, which began in the last quarter after the Trump administration approved a license for orders that AMD received in early 2025.

And without those sales to China which generated $390 million, AMD's data-center segment would have missed estimates for the fourth quarter.

AMD said it expects revenue of about $9.8 billion this quarter, plus or minus $300 million. That's down from $10.27 billion in the fourth-quarter which was up 34% year-on-year and ahead of LSEG ‌estimates for $9.67 billion.

PALES ‌NEXT TO NVIDIA

Though AMD is seen as one of the ‌few ⁠contenders ​that can seriously ‌challenge Nvidia, investors noted the stark contrast between the two companies' performances. AMD expects an adjusted gross margin of 55% this quarter. Nvidia has said it expects adjusted gross margin in the mid-70% range during its fiscal 2027.

"The expectations for large blowout quarters for AI-related hardware companies have skewed what the market is looking for," said Bob O'Donnell, president of TECHnalysis Research.

The forecast for the current first quarter includes $100 million from sales to China, where the situation remains "dynamic," AMD CEO Lisa Su said on a conference call with investors.

The US government ⁠has placed restrictions on the exports of advanced chips to China, but AMD received licenses to sell modified versions of its MI300 series ‌of AI chips there. Its MI308 chip competes with Nvidia's H20 ‍chip in China.

OPENAI SALES

AMD has accelerated its ‍product launches and is moving into selling full AI systems to better compete against Nvidia, which now ‍provides "rack-scale" systems that combine GPUs, CPUs and networking gear.

Last year, it entered into a multi-year deal to supply AI chips to ChatGPT-owner OpenAI, which would bring in tens of billions of dollars in annual revenue and give the startup the option to buy up to roughly 10% of the chipmaker.

Su reiterated on Tuesday that the company ​expects sales of a new flagship AI server to OpenAI and others to rise rapidly in the second half of this year, saying a global memory-chip crunch will not ⁠slow its plans.

"I do not believe that we will be supply-limited in terms of the ramp that we put in place," Su said.

BEYOND OPENAI

As Big Tech and governments across the globe double down on investing in AI hardware, shares in Santa Clara, California-based AMD have doubled since the start of 2025, outperforming a 60% bump in the broader chip index.

But analysts remain concerned that AMD's success remains tied to a handful of customers that rivals such as Nvidia could try to poach. Reuters reported this week that Nvidia made a $20 billion move to hire most of chip startup Groq's founders after OpenAI held chip supply discussions with the startup.

"Growth appears concentrated in large deployments and specific regions, and China shipments are significant enough to influence a quarter," said eMarketer analyst Gadjo Sevilla.

Revenue in AMD's key data-center segment grew 39% to $5.38 billion in the ‌fourth quarter. But excluding sales of the MI308, which is a data-center chip, that revenue would have been $4.99 billion, below estimates of $5.07 billion.


Switch 2 Sales Boost Nintendo Results but Chip Shortage Looms

This photo taken on November 4, 2025 shows a woman taking photos of a Super Mario figure at the Nintendo Tokyo store in Tokyo. (AFP)
This photo taken on November 4, 2025 shows a woman taking photos of a Super Mario figure at the Nintendo Tokyo store in Tokyo. (AFP)
TT

Switch 2 Sales Boost Nintendo Results but Chip Shortage Looms

This photo taken on November 4, 2025 shows a woman taking photos of a Super Mario figure at the Nintendo Tokyo store in Tokyo. (AFP)
This photo taken on November 4, 2025 shows a woman taking photos of a Super Mario figure at the Nintendo Tokyo store in Tokyo. (AFP)

The runaway success of the Switch 2 console drove up Nintendo's net profit by more than 50 percent in the nine months to December, the Japanese video game giant said Tuesday.

But a global memory chip shortage, created by frenzied demand for artificial intelligence hardware, could push up manufacturing costs.

The Switch 2 became the world's fastest-selling games console after launching to a fan frenzy last summer.

It is the successor to the original Switch, which soared in popularity during the pandemic when games such as "Animal Crossing" struck a chord during long lockdowns.

Both are hybrid devices that can be connected to a TV or used on-the-go.

In April-December, net profit jumped 51.3 percent year-on-year to 358.9 billion yen ($2.3 billion), and revenue nearly doubled on-year to 1.9 trillion yen, Nintendo said.

But the firm kept its annual unit sales target for the Switch 2 steady at 19 million, and also held its full-year net profit forecast of 350 billion yen.

"Nintendo Switch 2 got off to a good start following its launch on June 5 and unit sales continued to grow through the holiday season," the company said.

Nearly 17.4 million Switch 2 devices were sold in the nine-month period, it added.

"Maintaining momentum is certainly a big focus for Nintendo," Krysta Yang of the Nintendo-focused Kit and Krysta Podcast told AFP.

A lack of heavy-hitting first-party new games for the Switch 2 in coming months risks hindering growth, although third-party titles such as "Resident Evil Requiem" should help fill the gap, she said.

Nintendo said Tuesday it planned to release "Mario Tennis Fever" this month and "Pokemon Pokopia" in March.

While the firm is diversifying into hit movies and theme parks, consoles remain the core of its business.

The Switch 1 has now sold 155.37 million units -- overtaking the Nintendo DS console to be its best-selling hardware of all time.

But soaring prices for memory chips, used in gaming consoles as well as phones, laptops and other electronics, will likely be a headwind for the company.

Their prices have been pushed up as chipmakers focus on producing the advanced memory chips in huge demand to power AI data centers.

"Nintendo and other console manufacturers are publicly keeping quiet about the impact of the shortage," gaming industry consultant Serkan Toto told AFP.

But "users can forget the past when consoles always became cheaper in tandem with component costs falling over time", with price hikes potentially on the way in 2026, he said.

Yang said she thought a price increase for the Switch 2 "is not out of the question" but added that Nintendo "would likely exhaust all other options" before doing so.